Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Other financing activities (2021)

Historic Other financing activities for Ocular Therapeutix (OCUL) over the last 2 years, with Q1 2021 value amounting to $275000.0.

  • Ocular Therapeutix's Other financing activities changed N/A to $275000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was $275000.0, marking a year-over-year change of. This contributed to the annual value of $5.2 million for FY2023, which is N/A changed from last year.
  • As of Q1 2021, Ocular Therapeutix's Other financing activities stood at $275000.0.
  • Ocular Therapeutix's Other financing activities' 5-year high stood at $275000.0 during Q1 2021, with a 5-year trough of $275000.0 in Q1 2021.